Part Number : NDC00182-1806-89 | Manufacturer : Goldline Laboratories Inc | ||
NSN : 6505-01-280-9924 (6505012809924) | |||
Item Name : Lorazepam Tablets Usp | CAGE Code : 63488 | ||
NIIN : 01-280-9924 (012809924) | |||
INC Code : 42310 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00182180689 |
Thank you for taking an interest in part number NDC00182-1806-89, that of which is listed with the description Lorazepam Tablets Usp; Manufactured by Goldline Laboratories Inc and listed alongside the NSN 6505012809924, part number NDC00182-1806-89 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00182-1806-89 | Manufacturer : Goldline Laboratories Inc | ||
NSN Number : 6505-01-280-9924 (6505012809924) | |||
Item Name : Lorazepam Tablets Usp | CAGE Code : 63488 | ||
NIIN : 012809924 |
Thank you for taking an interest in part number NDC00182-1806-89, that of which is listed with the description Lorazepam Tablets Usp; Manufactured by Goldline Laboratories Inc and listed alongside the NSN 6505012809924, part number NDC00182-1806-89 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-280-9924 Item PartTypeName: LORAZEPAM TABLETS | 6505 | 012809924 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | U | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC00182-1806-89 | 5 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT |
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
CQCT | PRIMARY CONTAINER TYPE | CARD |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 TABLETS |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
CSGS | ADMINISTRATION | ORAL |
FEAT | SPECIAL FEATURES | CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote